Single Vision spectacle lens
Single Vision spectacle lens is a medical device with 8 clinical trials. Currently 5 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
5
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
[Trial of device that is not approved or cleared by the U.S. FDA]
Visual Performance of Highly Aspherical Lenslet Spectacles in Children (Ancillary to WS10246)
Spectacle Films Utilising S.T.O.P.® Technology for Slowing Down Myopia Progression in Children
The A.R.R.E.S.T.® Spectacle Film Study
The P.A.U.S.E.® Spectacle Study
Clinical Trials (8)
[Trial of device that is not approved or cleared by the U.S. FDA]
Visual Performance of Highly Aspherical Lenslet Spectacles in Children (Ancillary to WS10246)
Spectacle Films Utilising S.T.O.P.® Technology for Slowing Down Myopia Progression in Children
The A.R.R.E.S.T.® Spectacle Film Study
The P.A.U.S.E.® Spectacle Study
The Evaluation of Safety and Myopia Progression Control Using Novel Spectacle Lens
Myopia Control With a Innovative Spectacle Lens
Myopia Control Effect of DIMS Spectacle Lenses in Czech Children and Young Adults
All 8 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 8